Related Experiment Video

Updated: Feb 9, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

16.8K

Cardiovascular risk in chronic kidney disease: what is new in the pathogenesis and treatment?

Angelika Bazyluk1, Jolanta Malyszko1,2, Edyta Zbroch1

  • 1a 2-nd Department of Nephrology and Hypertension with Dialysis Centre , Medical University of Białystok , Bialystok , Poland.

Postgraduate Medicine
|May 31, 2018
PubMed

Insights

Chronic kidney disease (CKD) patients face high cardiovascular risks. Novel antidiabetic drugs may reduce this risk independently of blood sugar control, offering new hope for managing CKD complications.

Area of Science:

  • Nephrology
  • Cardiology
  • Endocrinology

Background:

  • Global prevalence of chronic kidney disease (CKD) is rising due to population aging.
  • Cardiovascular (CV) morbidity and mortality remain high in CKD patients despite advancements.
  • Diabetes mellitus is a leading cause of CKD, with projected increases in prevalence.

Purpose of the Study:

  • To discuss the underlying causes of elevated cardiovascular risk in CKD patients.
  • To explore strategies for reducing the cardiovascular burden in individuals with CKD.
  • To review the role of novel antidiabetic drugs in mitigating CV risk.

Main Methods:

  • Review of multicenter trial results concerning novel antidiabetic drugs.
  • Analysis of factors contributing to high CV risk in the CKD population.
  • Synthesis of current evidence on managing comorbidities in CKD.

Main Results:

  • Efficacy of novel antidiabetic drugs in reducing CV risk appears independent of glycemic control.
  • Diabetic nephropathy is a growing contributor to the overall CKD patient population.
  • CKD progression and associated comorbidities can be slowed, though the condition is irreversible.

Conclusions:

  • High cardiovascular risk is a critical issue in chronic kidney disease management.
  • Novel therapeutic strategies, potentially independent of glycemic control, are crucial for reducing CV risk in CKD.
  • Comprehensive management strategies are needed to slow kidney function decline and manage comorbidities in CKD patients.

Keywords:
Cardiovascular riskcardioprotectionchronic kidney diseaserenoprotection

More Related Videos

Fundus Photography as a Convenient Tool to Study Microvascular Responses to Cardiovascular Disease Risk Factors in Epidemiological Studies10:11

Fundus Photography as a Convenient Tool to Study Microvascular Responses to Cardiovascular Disease Risk Factors in Epidemiological Studies

Published on: October 22, 2014

19.7K
Author Spotlight: Efficacy of Auricular Pressure Bean Therapy in Reducing Wheezing Symptoms02:34

Author Spotlight: Efficacy of Auricular Pressure Bean Therapy in Reducing Wheezing Symptoms

Published on: May 10, 2024

1.9K

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
753
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
677
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
483
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
404
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
580
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.2K